Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma
Clinical trial NCT00060203 · COMPLETED
Trial details
- NCT number
- NCT00060203
- Sponsor
- Case Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-12-01
- Primary completion
- 2003-03-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.